Press Releases

12345678910
apexanalytix Named a Leader in the 2026 Gartner® Magic Quadrant™ for Supplier Risk Management Solutions
apexanalytix has been named a Leader in the 2026 Gartner® Magic Quadrant™ for Supplier Risk Management Solutions, recognized for both Completeness of Vision and Ability to Execute.
By apexanalytix · Via Business Wire · May 4, 2026
American College of Education Donates $4,500 in Gifts to Teachers' Treasures for Teacher Appreciation Week
The college has partnered with Teachers' Treasures for more than 10 years.
Via ACCESS Newswire · May 4, 2026
Stanley Martin Homes Completes Acquisition of United Homes Group
Stanley Martin Homes, LLC (“Stanley Martin Homes”) and United Homes Group, Inc. (“United Homes”) (NASDAQ: UHG) today announced that Stanley Martin Homes has completed its previously announced all-cash acquisition of United Homes for an enterprise value of approximately $221 million.
By United Homes Group, Inc. · Via Business Wire · May 4, 2026
DRVN Investors Have Opportunity to Lead Driven Brands Holdings Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, May 04, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Driven Brands Holdings Inc. (“Driven Brands” or “the Company”) (NASDAQ: DRVN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · May 4, 2026
Owlet Gives Moms the Ultimate Mother's Day Gift: More Confidence and Peace of Mind
Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today shared its 2026 Mother’s Day campaign, which aims to support moms and give them more confidence. The two-week campaign encourages moms to let Owlet do more with steep discounts on its products and a new, exclusive partnership with Divi, the Growth Care™ brand founded by Dani Austin.
By Owlet, Inc. · Via Business Wire · May 4, 2026
The Rise of AI 3D Creation: How Tripo Studio Makes 3D Modeling Accessible to Everyone
3D modeling has long been seen as a “professional-only” skill—reserved for artists, designers, and engineers with years of training. Whether you’re a hobbyist wanting to create 3D art, a small business owner needing product models, or a teacher looking to bring lessons to life, the barrier to entry has always been high: expensive software, steep […]
Via Worldnewswire · May 4, 2026
Quiver Bioscience Receives NIH HEAL Initiative Award to Advance Nav1.7 Antisense Therapy for Chronic Pain Through Early Clinical Trials
Quiver Bioscience (“Quiver”), a discovery platform, technology and therapeutics company advancing programs for the treatment of serious central nervous system (CNS) disorders and chronic pain, today announced receipt of a multi-year grant from the National Institutes of Health (NIH) to advance its lead Nav1.7-targeted antisense oligonucleotide (ASO) QV-2421 through first-in-human clinical trials for chronic neuropathic pain pending achievement of program milestones. The award provides up to $9.3 million in direct funding and access to NIH-supported development resources, including CMC and IND-enabling studies, to support key preclinical activities and an initial clinical trial, representing total potential development support of approximately $20 million.
By Quiver Bioscience · Via Business Wire · May 4, 2026
Gyre Therapeutics Completes Acquisition of Cullgen to Create U.S.- and China-based Fully Integrated Biopharmaceutical Company
SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- Gyre Therapeutics, Inc. (“Gyre”, “Gyre Therapeutics” or the “Company”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic diseases, today announced the closing of its acquisition of Cullgen Inc. (Cullgen), a privately-held, clinical-stage biopharmaceutical company focused on the discovery and development of targeted protein degrader (TPD) and degrader antibody conjugate (DAC) therapies, in an all-stock transaction valued at approximately $300 million.
By Gyre Therapeutics Inc. · Via GlobeNewswire · May 4, 2026
INVESTOR REMINDER: Berger Montague Notifies Gossamer Bio, Inc. (NASDAQ: GOSS) Investors of a Class Action Lawsuit and Deadline
PHILADELPHIA, May 04, 2026 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces a class action lawsuit against Gossamer Bio, Inc. (NASDAQ: GOSS) (“Gossamer” or the “Company”) on behalf of investors who purchased or acquired Gossamer shares during the period from June 16, 2025 through February 20, 2026 (the “Class Period”).
By Berger Montague · Via GlobeNewswire · May 4, 2026
Worksport (NASDAQ:WKSP) Invited to Present at D. Boral 2026 Global Conference
Worksport CEO Steven Rossi will share the Company's growth story with institutional investors in New York City as Worksport continues expanding commercial execution, product availability, and investor visibility. Existing shareholders may also request meetings with Worksport management on May 6 and May 7.
Via ACCESS Newswire · May 4, 2026
Borussia Dortmund Publishes Preliminary Figures for the Third Quarter (Q3) of the 2025/2026 Financial Year
DORTMUND, DE / ACCESS Newswire / May 4, 2026 / The cumulative figures for the first three quarters (period from 1 July 2025 to 31 March 2026) are as follows:
Via ACCESS Newswire · May 4, 2026
Reel-Funding Group Launches Multi-Fund Platform to Finance Independent Film Slates
JACKSONVILLE, Fla., May 04, 2026 (GLOBE NEWSWIRE) -- Reel-Funding Group (RFG), a film finance and production company, today announced the launch of a multi-fund investment platform purpose-built to finance and produce independent films through partnerships with established and emerging filmmakers.
By REEL-FUNDING GROUP · Via GlobeNewswire · May 4, 2026
Polyrizon Announces U.S. Patent Expansion for Its Intranasal Drug Delivery Platform
Raanana, Israel, May 04, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, today announced the submission of amended claims in its U.S. patent application for its proprietary intranasal drug delivery platform.
By Polyrizon Ltd. · Via GlobeNewswire · May 4, 2026
NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, May 04, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Nektar Therapeutics (“Nektar” or “the Company”) (NASDAQ: NKTR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · May 4, 2026
WOW24-7 Launches Automation & AI Department to Scale Enterprise AI in Customer Experience
San Antonio, Texas--(Newsfile Corp. - May 4, 2026) - WOW24-7, a G2 Grid Leader in Contact Center Outsourcing delivering enterprise...
Via Newsfile · May 4, 2026
KinderCare Celebrates Teachers with Child Care Tuition Support
KinderCare Learning Companies, Inc. (NYSE: KLC) (“KinderCare”), the nation’s leading provider of high-quality early childhood education and care, is celebrating Teacher Appreciation Week with a special thank you to K-12 teachers and district staff. KinderCare will offer staff and teachers at any school district that its before- and after-school brand Champions operates in with a tuition benefit of 10% off child care at any KinderCare Learning Center (KCLC).
By KinderCare · Via Business Wire · May 4, 2026
Pinnacle West Reports 2026 First-Quarter Financial Results
Pinnacle West Capital Corp. (NYSE: PNW) today reported consolidated net income attributable to common shareholders of $32.9 million, or $0.27 per diluted share of common stock, for the quarter ended March 31, 2026. This result compares with a consolidated net loss attributable to common shareholders of $4.6 million, or a loss of $0.04 per diluted share, for the same period in 2025.
Infleqtion to Report First Quarter 2026 Financial Results on May 14, 2026
Infleqtion (NYSE: INFQ) (the “Company”), a global leader in quantum computing and quantum sensing powered by neutral-atom technology, today announced that it will release its financial results for the quarter ended March 31, 2026, on Thursday, May 14, 2026, after the financial markets close.
By Infleqtion · Via Business Wire · May 4, 2026
Precious Metals & Critical Minerals Virtual Investor Conference Agenda Announced for May 5th – 7th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
NextGen Healthcare Receives Bronze Stevie® Award for “AI-Driven Success in Action” in 2026 American Business Awards®
NextGen Healthcare, a leading provider of innovative, cloud-based healthcare technology solutions, has received a Bronze Stevie® Award for “AI-Driven Success in Action” in the 2026 American Business Awards®, the premier U.S. business awards program.
By NextGen Healthcare, Inc. · Via Business Wire · May 4, 2026
Atlas Lithium Corporation to Present at the Precious Metals & Critical Minerals Virtual Investor Conference May 5th
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
Niagen Bioscience Launches Niagen Plus Telehealth Platform, Unveiling At-Home Injection Kit Offering
Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the launch of its clinician-directed telehealth platform under Niagen™ Plus, enabling eligible patients in the U.S. to access prescription-only, pharmaceutical-grade Niagen® (patented nicotinamide riboside chloride, NRCl) from home with the first-of-its-kind Niagen® At-Home Injection Kit. The launch marks Niagen Bioscience's first direct-to-client access model and introduces at-home subcutaneous administration, eliminating the need for an in-person doctor’s or drug store visit, extending the reach of Niagen Plus beyond clinic visits.
By Niagen Bioscience, Inc · Via Business Wire · May 4, 2026
Dot Ai to Host First Quarter 2026 Earnings Call on May 11 at 4:30 p.m. Eastern Time
LAS VEGAS, NV / ACCESS Newswire / May 4, 2026 / Dot Ai (Nasdaq:DAIC) ("Dot Ai" or the "Company"), an IoT and AI-based SaaS company redefining asset intelligence for industrial technology, will release financial results for the first quarter ended March 31, 2026 after market close on May 11, 2026.
Via ACCESS Newswire · May 4, 2026
Kopin Corporation to Host First Quarter 2026 Earnings Call on Tuesday, May 12, 2026 at 8:30 AM Eastern Time
Kopin Corporation (Nasdaq: KOPN) (“Kopin” or the “Company”), a leading provider of application-specific optical systems and high-performance microdisplays for defense, training, enterprise, industrial, consumer and medical products, today announced it will release select unaudited financial results for the first quarter ended March 28, 2026 before market open on Tuesday, May 12, 2026.
By Kopin Corporation · Via Business Wire · May 4, 2026
NeuroOne(R) Regains Compliance With Nasdaq Listing Requirement
EDEN PRAIRIE, MINN. - May 4, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company dedicated to transforming the surgical diagnosis and treatment of neurological disorders, today announced that it has received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it has regained compliance with Nasdaq Marketplace Rule 5550(a)(2) (the “Minimum Bid Price Requirement”) and the matter is closed.
Via TheNewswire.com · May 4, 2026
NeuroOne(R) Regains Compliance With Nasdaq Listing Requirement
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · May 4, 2026
NV-387 for The Treatment of Measles is Granted Orphan Drug Designation by The US FDA
SHELTON, CT / ACCESS Newswire / May 4, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, announced today that its clinical stage, broad-spectrum, antiviral drug NV-387 has been granted an "Orphan Drug Designation" (ODD) by the US FDA Office of Orphan Products Development (OOPD).
Via ACCESS Newswire · May 4, 2026
Caldwell Announces TSX Approval of Normal Course Issuer Bid
TORONTO, ON / ACCESS Newswire / May 4, 2026 / Talent acquisition firm The Caldwell Partners International Inc. ("Caldwell" or the "Company") (TSX:CWL)(OTCQX:CWLPF) announces that the Toronto Stock Exchange (the "TSX") has accepted Caldwell's notice to make a normal course issuer bid (the "2026 Bid") to purchase for cancellation up to 2,023,669 common shares in the capital of the Company ("Common Shares") in total, being 10% of the public float of 20,236,698Common Shares as at April 22, 2026, to be transacted through the facilities of the TSX or through a Canadian alternative trading system, at prevailing market prices or as otherwise permitted. The actual number of Common Shares that may be purchased pursuant to the 2026 Bid will be determined by management and the Investment Committee of the Company ("Management"). The 2026 Bid will commence on May 6, 2026 and will terminate on May 5, 2027, or such earlier time as the 2026 Bid is completed or terminated at the option of Caldwell.
Via ACCESS Newswire · May 4, 2026
Jaguar Health Expands Neonorm Franchise with Introduction of Neonorm Dog for Companion Animal Gut Health
Neonorm Dog extends Jaguar's existing Neonorm product franchise beyond foals and calves to provide dog owners with access to a plant-based product designed to support normal stool formation, gut hydration, and bowel health
Via ACCESS Newswire · May 4, 2026
AimwellBio Reports Strong Early Demand From Hospital Systems and Researchers as FHIN Founding Cohort Takes Shape
NEW YORK CITY, NY / ACCESS Newswire / May 4, 2026 / Aimwell Partners Inc. (OTCID:AIMN), parent company of AimwellBio, today announced that initial engagement with hospital systems and hospitalists has generated strong early-stage interest in the company's Federated Health Intelligence Network (FHIN) founding cohort. Following a series of meetings conducted over the past two weeks, including a session that resulted in a hospital system expressing interest in onboarding its research staff for platform evaluation, the company is accelerating its FHIN enrollment timeline and pursuing memberships in multiple scientific and medical associations to broaden network credibility and contributor access.
Via ACCESS Newswire · May 4, 2026
C2 Blockchain Advances Toward 1 Billion DOG (Bitcoin) Treasury as Accumulation Continues
Treasury Increased by Approximately 41.2 Million DOG Since Prior Disclosure
Via ACCESS Newswire · May 4, 2026
Gladstone Commercial Corporation Earnings Call and Webcast Information
MCLEAN, VA / ACCESS Newswire / May 4, 2026 / Gladstone Commercial Corporation (Nasdaq:GOOD) announces the following event:
Via ACCESS Newswire · May 4, 2026
NerdWallet Announces Winners of Its 2026 Best-Of Awards for Mortgage Lenders
NerdWallet, Inc. (Nasdaq: NRDS), which provides trustworthy financial guidance to consumers and small and mid-sized businesses (SMBs), today announced the winners of its 2026 Best-Of Awards for Mortgage Lenders.
By NerdWallet, Inc. · Via Business Wire · May 4, 2026
Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it will present new data analyses for vutrisiran in patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) at Heart Failure 2026, a scientific congress of the European Society of Cardiology, taking place May 9-12, 2026, in Barcelona, Spain.
Thermo Fisher Scientific Unveils an Integrated Platform to Advance Scalable Cell Therapy Manufacturing
Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Gibco™ CTS™ DynaXS™ Single Use Bioreactor, a purpose-built expansion platform designed to help cell therapy developers scale manufacturing with precise control, flexibility, and regulatory readiness.
By Thermo Fisher · Via Business Wire · May 4, 2026
Sculptor Real Estate and Trinity Investments Acquire JW Marriott Marco Island Beach Resort from MassMutual
A joint venture between Sculptor Real Estate Income Strategy—Sculptor Real Estate’s core plus strategy focused on differentiated, stabilized, income-producing real estate—and Trinity Investments (“Trinity”), a global hospitality-focused investment firm, announced today the acquisition of the JW Marriott Marco Island Beach Resort (the “Property”), a luxury beachfront resort located on Florida’s Gulf Coast, from MassMutual, a leading mutual life insurance company.
By Trinity Investments · Via Business Wire · May 4, 2026
The O.H.I.O. Fund Reports Strong Q1 Momentum as Committed Capital Climbs to $647 Million, Makes Four New Investments
The O.H.I.O. Fund today reported strong first-quarter momentum, increasing total committed capital to its private funds from $356 million at the end of Q4 2025 to $647 million on March 31, 2026. The O.H.I.O. Fund is a private fund investment adviser seeking to generate strong returns for investors while supporting economic growth in Ohio. The increase was driven by more than $290 million in commitments from 18 new investors in the firm’s evergreen fund. These commitments reflect continued investor confidence (155 investors to date) in the firm’s thesis of deploying Ohio-based capital into Ohio-based opportunities. The strategy is supported by Ohio’s large and diverse economy and a proprietary network that enhances the sourcing and evaluation of investment opportunities across the state.
By The O.H.I.O. Fund · Via Business Wire · May 4, 2026
Gloo Completes Acquisition of EnterpriseMarketdesk (EMD) Bringing AI-enabled Workday Services and Expertise to the Gloo Platform
Gloo (Nasdaq: GLOO), a leading technology platform serving the faith and flourishing ecosystem, today announced it has completed the acquisition of EnterpriseMarketdesk (EMD), an established Workday Services Partner providing consulting, implementation, and support services to nonprofit and mid-market organizations. The transaction, which was announced on April 14, brings a comprehensive suite of AI-enabled Workday services and expertise onto the Gloo platform.
By Gloo · Via Business Wire · May 4, 2026
Schrödinger to Participate in Upcoming Investor Conferences
Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in the following conferences in May:
By Schrödinger · Via Business Wire · May 4, 2026
CMOs Gain Influence, But Only 38% Say the Role Is Fully Set Up for Success
Chief marketing officers are operating with greater influence, stronger executive relationships and broader use of artificial intelligence than ever before, according to new research released today by Arketi Group and JM Search. Yet many marketing leaders say structural challenges continue to limit the effectiveness of the role.
By Arketi Group · Via Business Wire · May 4, 2026
National Life Group Names Jason Doiron CEO of NLG Capital to Lead the Next Phase of Growth
National Life Group recently named Jason Doiron Chief Executive Officer of its investment affiliate, NLG Capital, as the organization continues to focus on strategic growth. Doiron is also Executive Vice President and Chief Investment Officer of National Life Group.
By National Life Group · Via Business Wire · May 4, 2026
Everbridge Honors 2026 Excellence in Resilience Award Winners at Discover Resilience
Everbridge, Inc., the global leader in High Velocity Critical Event Management (CEM) and national public warning solutions, today announced the recipients of the 2026 Excellence in Resilience Awards, presented during a special ceremony at Discover Resilience, the company’s annual customer conference held April 19–22 in Chicago.
By Everbridge, Inc. · Via Business Wire · May 4, 2026
Service Robotics Growth Accelerates as Global Demand Fuels Strategic Expansion
AUSTIN, Texas, May 04, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: Global demand for service robotics is accelerating as industries increasingly turn to automation to address labor shortages, rising costs and operational inefficiencies. According to the International Federation of Robotics, service robot adoption continues to expand worldwide, with hundreds of thousands of units deployed annually and strong growth expected across hospitality, logistics and healthcare sectors. Market forecasts reinforce this trajectory, projecting the global service robotics market to grow from roughly $31 billion in 2026 to more than $131 billion by 2034, reflecting sustained double-digit growth driven by AI and automation adoption. Nightfood Holdings Inc. (OTC: NGTF) (Profile), (dba as TechForce Robotics), is positioning itself at the center of this transformation by focusing on real-world deployment, scalable infrastructure and strategic partnerships that enable global expansion in the AI robotics space. The company is focused on becoming an innovative leader in the robotics segment, aligned with others in the space, including Microsoft Corporation (NASDAQ: MSFT), ABB Ltd. (OTC: ABBNY), Rockwell Automation Inc. (NYSE: ROK) and Richtech Robotics Inc. (NASDAQ: RR).
By AINewsWire · Via GlobeNewswire · May 4, 2026
Alico to Present at the LD Micro Invitational XVI
FORT MYERS, Fla., May 04, 2026 (GLOBE NEWSWIRE) -- Alico, Inc. (“Alico” or the “Company”) (Nasdaq: ALCO) today announced that John Kiernan, the Company’s President and Chief Executive Officer, will present and host one-on-one meetings with investors at the LD Micro Invitational XVI Conference, taking place on May 17-19, 2026 in Los Angeles, CA.
By Alico, Inc. · Via GlobeNewswire · May 4, 2026
Satellogic Expands Global Sales Force with Senior Defense and Intelligence Industry Veterans
NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) -- Satellogic, Inc. (NASDAQ: SATL), a vertically integrated geospatial company delivering high-resolution Earth Observation (EO) at unprecedented scale and economics, today announced the addition of three senior industry veterans to its global sales organization: Matt Clark, Brett Davis, and Jonathan Lee.
By Satellogic, Inc. · Via GlobeNewswire · May 4, 2026
Bicara Therapeutics to Report First Quarter 2026 Financial Results and Business Updates on May 11, 2026, at 8:30 AM ET
BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced that it will report first quarter 2026 financial results and business updates before the market opens on Monday, May 11, 2026. Bicara will host a conference call to discuss the financial results and business updates at 8:30 a.m. ET the same day. Individuals may register for the conference call by clicking the link here. Once registered, participants will receive dial-in details and a unique PIN that will allow them to access the call. To access the live webcast, please visit the “Events & Presentations” section within the Investors page on the Bicara website. A replay of the webcast will be available for 30 days following the event.
By Bicara Therapeutics Inc. · Via GlobeNewswire · May 4, 2026
Newtek Bank, N.A. Customers Now Have the Ability to Receive Instant Payments Through the FedNow® Service and RTP® Network 24/7/365
BOCA RATON, Fla., May 04, 2026 (GLOBE NEWSWIRE) -- NewtekOne, Inc. (NASDAQ: NEWT) (“NewtekOne”) announced that its bank subsidiary, Newtek Bank, N.A. (“Newtek Bank”), now offers its commercial banking customers the capability to receive instant payments through the Federal Reserve’s FedNow® Service and The Clearing House’s RTP® network twenty-four hours a day, seven days a week, 365 days per year.
By NewtekOne, Inc. · Via GlobeNewswire · May 4, 2026
Liquidia Corporation to Report First Quarter 2026 Financial Results on May 11, 2026
MORRISVILLE, N.C., May 04, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, announced today that it will report its first quarter 2026 financial results on Monday, May 11, 2026. The company will host a live webcast at 8:30 a.m. Eastern Time to discuss its financial results and provide a corporate update.
Raven Capital Sells Stake in Outback Presents’ Comedy Business to AEG Presents in Milestone Transaction
LOS ANGELES, May 04, 2026 (GLOBE NEWSWIRE) -- Raven Capital (“Raven”), an alternative investment firm specializing in asset-based, non-sponsor private credit, today announced that its portfolio company, Outback Presents, has completed the sale of a minority stake in its comedy business to AEG Presents, a leading global sports and live entertainment company.
By Raven Capital · Via GlobeNewswire · May 4, 2026
Firefly Aerospace Subsidiary SciTec Receives Agreement to Advance Space Force’s Space-Based Missile Defense Under Golden Dome
SciTec selected to support $3.2 billion Space-Based Interceptor program for Golden Dome
By Firefly Aerospace · Via GlobeNewswire · May 4, 2026